BIOTALYS NV (BTLS.BR) Stock Balance Sheet
EBR:BTLS - Euronext Brussels - BE0974386188 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 22.64M | 21.57M | 34.10M | 56.11M | 23.10M | |||
| Marketable Securities | 2.11M | 2.10M | 2.10M | 2.10M | 2.10M | |||
| Receivables | 970.00K | 750.00K | 820.00K | 450.00K | 230.00K | |||
| Other Current Assets | 522.00K | 490.00K | 746.00K | 280.00K | 80.00K | |||
| Total Current Assets | 26.24M | 24.91M | 37.76M | 58.94M | 25.51M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.81M | 8.43M | 9.00M | 9.29M | 8.96M | |||
| Intangibles | 574.00K | 642.00K | 596.00K | 670.00K | 790.00K | |||
| Other Non-Current Assets | 3.12M | 2.60M | 2.16M | 1.38M | 1.00M | |||
| Total Non-Current Assets | 10.51M | 11.67M | 11.76M | 11.33M | 10.75M | |||
| TOTAL ASSETS | 36.75M | 36.58M | 49.52M | 70.27M | 36.26M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.15M | 1.23M | 1.16M | 1.19M | 890.00K | |||
| Accrued Expenses | 1.52M | 1.33M | 1.39M | N/A | N/A | |||
| Accounts Payable | 1.17M | 1.25M | 2.73M | 3.12M | 3.30M | |||
| Other Current Liabilities | 925.00K | 1.73M | 674.00K | 900.00K | 1.96M | |||
| Total Current Liabilities | 4.77M | 5.55M | 5.96M | 5.21M | 6.15M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.69M | 4.84M | 5.34M | 6.04M | 4.33M | |||
| Other Non-Current Liabilities | 681.00K | 626.00K | 105.00K | 110.00K | 140.00K | |||
| Total Non-Current Liabilities | 4.38M | 5.47M | 5.44M | 6.15M | 4.46M | |||
| TOTAL LIABILITIES | 9.14M | 11.01M | 11.40M | 11.36M | 10.61M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -7.14M | -36.12M | -16.60M | -54.36M | -37.85M | |||
| Additional Paid In Capital | 29.21M | 15.49M | 10.16M | 31.30M | 680.00K | |||
| Common Shares | 5.54M | 46.20M | 44.55M | 81.97M | 62.82M | |||
| Other Shareholders' Equity | N/A | 1.00K | -1.00K | 3.00K | N/A | |||
| Shares Outstanding | 37.46M | 32.09M | 30.95M | 30.81M | 30.02M | |||
| Tangible Book Value per Share | 0.72 | 0.78 | 1.21 | 1.89 | 0.83 | |||
| Total Shareholders' Equity | 27.61M | 25.57M | 38.11M | 58.92M | 25.65M | |||
| TOTAL LIABILITIES AND EQUITY | 36.75M | 36.58M | 49.52M | 70.27M | 36.26M | |||
| Statistics | ||||||||
| Debt/Equity | 0.13 | 0.19 | 0.14 | 0.10 | 0.17 | |||
| Current Ratio | 5.50 | 4.49 | 6.34 | 11.31 | 4.15 | |||
| Return On Assets (ROA) | -35.89% | -56.07% | -45.91% | -24.09% | -29.65% | |||
| Return On Equity (ROE) | -47.77% | -80.21% | -59.64% | -28.73% | -41.91% | |||
All data in EUR , ROIC based on taxRate of 0.25